Announcement of Changes in BioNB’s Board of Directors

Andrew Byrne October 23, 2020

On Thursday, October 22nd, 2020, BioNB held its Annual General Meeting (AGM). There were several changes in our Board of Directors that we would like to acknowledge and highlight.

Firstly, the entire board and staff of BioNB would like to thank Dr. Murray McLaughlin, who stepped down from the Board of Directors after 16 years of service, which includes his roles as President, Chairperson and Director, in this volunteer role. Dr. McLaughlin brought valuable expertise to the organization and had an impact on the growth of the bioeconomy in New Brunswick and the organizational growth of BioNB. We wish him all the best as he continues to champion the bioeconomy throughout the country.

Pat Whalen, LuminUltra’s President and CEO, has been our Chairperson for 3 years and today we are announcing that he is stepping from the Chair role, but remaining on as a board member. Before taking on the role of Chairperson of the Board, Pat was a Director for one year and a Vice-Chairperson for 3 years. We thank him for his leadership throughout his tenure and we are excited to see him stay on as his support will continue to be invaluable.

We are pleased to announce that Dr. David Magee, Vice-President (Research), University of New Brunswick has been appointed the new Chairperson of the Board of BioNB and Brennan Sisk, Co-Founder, Mycodev Group, will be the Vice-Chair.

This is an exciting time for BioNB as we pursue the development of several sectors in the bioeconomy and continue to help companies grow and commercialize their bioscience ideas. We know that with the board’s help, BioNB will continue to grow and bring the bioeconomy to the forefront of New Brunswick’s industries, thereby making this province a more resilient and innovative player on the world stage. We thank both David and Brennan for accepting these nominations and we are thrilled to see what the future holds.

Post Tags